Hero Image

Biomedicines Webinar | Molecular Targets for Biological Therapies of Severe Asthma

21 February 2023
10:00 (CET)
Online

Meet Our Speakers

View all speakers
Prof. Dr. Girolamo Pelaia

Prof. Dr. Girolamo Pelaia

Department of Health Sciences, “Magna Graecia” University of Catanzaro, Italy;
Girolamo Pelaia works at “Magna Graecia” University of Catanzaro, Italy, where he is Full Professor of Pulmonary Medicine, Director of the Postgraduate Specialization School of Respiratory Diseases, and Head of the Respiratory Disease Unit. He was born on 15 August 1960 in Catanzaro, Italy. In 1985 he received a degree in Medicine and Surgery, with distinction (“summa cum laude”), from the University of Reggio Calabria, Italy, and in 1989 he graduated with distinction (“summa cum laude”) as a Specialist in Respiratory Diseases at the University of Naples “Federico II”, Italy. He subsequently worked from 1990 to 1992 as a Postdoctoral Fellow at Georgetown University School of Medicine, Washington, D.C., USA. The clinical and research activities of Professor Pelaia primarily deal with the pathophysiology and treatment of asthma and chronic obstructive pulmonary disease (COPD). In particular, he is interested in the cellular and molecular mechanisms underlying the therapeutic effects of inhaled corticosteroids, long-acting bronchodilators, and anti-asthma biologic drugs. He has authored or co-authored more than 150 original articles and reviews published in international peer-reviewed journals, as well as several book chapters.

Sponsors and Partners

Organizer


MDPIBiomedicines
Webinar Content

On Tuesday, 21 February 2023, MDPI and the Biomedicines Journal organized the 6th Biomedicines webinar, entitled "Molecular Targets for Biological Therapies of Severe Asthma".

The introduction was held by the Chair of the webinar, Prof. Dr. Girolamo Pelaia. He works at “Magna Graecia” University of Catanzaro, Italy, where he is Full Professor of Pulmonary Medicine, Director of the Postgraduate Specialization School of Respiratory Diseases, and Head of the Respiratory Disease Unit.

The first presentation was held by Prof. Dr. Francesco Blasi with his presentation "How Registries Can Improve Severe Asthma Management". He is Professor of Respiratory Medicine Department of Pathophysiology and Transplantation at the University of Milan, Italy, as well as Head of Internal Medicine Department and Respiratory Unit of the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy.

The second presenter was Prof. Dr. Enrico Heffler who talked about "Biologicals for Severe Asthma and Its Comorbidities". He is the Director of the Postgraduate Residency Program for Allergology and Immunology, Associate Professor of Internal Medicine at Humanitas Research Hospital, Allergist, Clinical Immunologist and Assistant at Personalized Medicine, Asthma and Allergy Unit, Humanitas Research Hospital.

The presentations were followed by a Q&A and a discussion, moderated by the Chair Prof. Dr. Girolamo Pelaia. The webinar was offered via Zoom and required registration to attend. The full recording can be found here on Sciforum website. In order to stay updated on the next webinars on Biomedicines be sure to sign up for our newsletter by clicking on “Subscribe” at the top of the page.

Content Locked
You need to log in and have a confirmed registration to view this content.
Relevant SI
Molecular Targets for Biological Therapies of Severe Asthma
Guest Editor: Prof. Dr. Girolamo Pelaia
Deadline for manuscript submissions: closed (31 August 2022)

Powered by Sciforum
Disclaimer
Terms and ConditionsPrivacy PolicyAccessibility